115 Engineered T cells directed at tumors with defined allelic loss
Sign Up to like & getrecommendations! Published in 2020 at "Journal for ImmunoTherapy of Cancer"
DOI: 10.1136/jitc-2020-sitc2020.0115
Abstract: Background Cell therapy, with all its promise as a powerful solid-tumor modality, is still hampered by the fundamental obstacle of cancer therapy: the acute shortage of truly tumor-specific targets. It is well known that an… read more here.
Keywords: tumor; signal integration; 115 engineered; cancer ... See more keywords